Wanbury Pharma Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U33119MH2012PLC237381 Incorporated 31 October 2012 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2022
-
Latest filing
EBITDA · FY 2022
Locked
In full report
Net profit · FY 2022
Locked
In full report
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
14 yrs
Est. 2012
Last financials
Mar 2025
Balance sheet date

About Wanbury Pharma Limited

Data last updated:

Wanbury Pharma Limited is a public limited company based in Navi Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 October 2012, the company has been in operation for over 14 years.

Registered with ROC Mumbai under CIN U33119MH2012PLC237381.

Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹5 Lakh. It is led by directors including Vijaykumar Shivaji Ayare and Venkat Kumar Ketha.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: D – 28/11 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706.

The company is associated with 1 brand - Wanbury Limited.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wanbury.com.

Company Details of Wanbury Pharma Limited
CIN U33119MH2012PLC237381
Registration Number 237381
Incorporation Date 31 October 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    D – 28/11 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706
  • Industry
    Pharma, Drug Formulation & Development
Company report
Wanbury Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Wanbury Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Wanbury Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Wanbury Pharma

Wanbury Pharma operates one associated brand: Wanbury Limited. Each brand links to its own profile.

BrandDescriptionWebsite
Anti-diabetic drugs and active pharmaceutical ingredients are manufactured.wanbury.com

Competitors & Alternatives of Wanbury Pharma

Brands and companies operating in the same space as Wanbury Pharma Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.

CompetitorDescriptionLocationFounded
Concord Biotech Concord Biotech APIs and enzymes are manufactured through fermentation by the CDMO.Ahmedabad, India, India2000
BDR Pharmaceuticals Internationals BDR Pharmaceuticals Internationals APIs and finished products are developed and manufactured.Mumbai, India, India2003
Almac Group Almac Group Integrated CDMO services for biopharma R&D and manufacturing are offered.Craigavon, United Kingdom, United Kingdom2001
Indoco Remedies Indoco Remedies APIs manufacturing and formulation services are provided in therapeutic segments.Mumbai, India, India1947
Pharmaceutics International Pharmaceutics International Pharmaceutical dosage forms are manufactured by this CDMO.Hunt Valley, United States, United States1994
Aurobindo Pharma Aurobindo Pharma Generic biocatalytic solutions are provided for pharmaceutical applications.Hyderabad, India, India1986
Seqens Seqens Contract manufacturing services for small molecules and peptides are provided.Ecully, France, France2003
Asymchem Asymchem APIs and peptides are developed and manufactured by Asymchem.Morrisville, United States, United States1995
Aptuit Aptuit Contract research and development services for small molecules are offered.Greenwich, United States, United States2004
Continuus Pharma Continuus Pharma MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule developmentWoburn, United States, United States2012

Business Activity of Wanbury Pharma

Wanbury Pharma operates primarily in the manufacturing sector. One business activity is registered with the MCA.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
LockedManufacturingLockedChemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Detailed business activity records for Wanbury Pharma Limited

Activity codes and each activity's share of turnover are in the company report.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Wanbury Pharma

Wanbury Pharma Limited is audited by KAPOOR & PAREKH ASSOCIATES for the financial year 2022.

NameStatusAppointment DateCessation Date
KAPOOR & PAREKH ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history for Wanbury Pharma Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Wanbury Pharma Limited

Wanbury Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vijaykumar Shivaji AyareDirector31 Oct 201213 Years 11 MonthsCurrent
Venkat Kumar KethaDirector15 Dec 20223 Years 9 MonthsCurrent
Sunil Vasudev KotyankarDirector15 Dec 20223 Years 9 MonthsCurrent

Financials of Wanbury Pharma Limited FY 2025 filings available

Premium access

Ten-year financial statements for Wanbury Pharma Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Wanbury Pharma

Premium access

Shareholding and ownership data for Wanbury Pharma Limited

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Wanbury Pharma

Wanbury Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Wanbury Pharma

Employment history and EPFO contributions of people linked to Wanbury Pharma.

Premium access

Employee and EPFO history for Wanbury Pharma Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Wanbury Pharma

Premium access

GST registrations and filing compliance for Wanbury Pharma Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Wanbury Pharma

Premium access

Credit ratings, litigation, and regulatory alerts for Wanbury Pharma Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Wanbury Pharma

Premium access

MSME payment history for Wanbury Pharma Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Wanbury Pharma

Premium access

Corporate group structure for Wanbury Pharma Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Wanbury Pharma

Premium access

MCA filings and documents for Wanbury Pharma Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Wanbury Pharma

Activity
30 Sep 2025
Wanbury Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Wanbury Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
15 Dec 2022
Venkat Kumar Ketha was appointed as a Director on 15 Dec 2022 & has been associated with this company since 3 years 9 months.
Directors
15 Dec 2022
Sunil Vasudev Kotyankar was appointed as a Director on 15 Dec 2022 & has been associated with this company since 3 years 9 months.
Directors
31 Oct 2012
Vijaykumar Shivaji Ayare was appointed as a Director on 31 Oct 2012 & has been associated with this company since 13 years 11 months.
Activity
31 Oct 2012
Wanbury Pharma Limited was registered on 31 Oct 2012 with Roc Mumbai & aged 13 years 11 months as per MCA records.

Frequently Asked Questions about Wanbury Pharma Limited

Wanbury Pharma is an active public limited company in the pharma sector based in Navi Mumbai, Maharashtra, India. It was incorporated on 31 October 2012 (14+ years old) and is registered under CIN U33119MH2012PLC237381.

The current directors of Wanbury Pharma are:

The primary industry of Wanbury Pharma is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Wanbury Pharma can be reached at the registered office: D – 2811 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706, or through the website wanbury.com.

The authorised capital is ₹1 Cr, and the paid-up capital is ₹5 Lakh.

The company has its registered office at D – 2811 Midc Ttc Industrial Area Turbhe, Navi Mumbai, Maharashtra, India – 400706.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available